drugset / Trial / NCT04088305
Vancomycin Dosage Strategy Based on a Trough Concentration Model
RandomizedParallel-groupOpen-labelTreatment
Summary
Study design: Allocation: Randomized Endpoint classification: Efficacy study Masking: Open label Primary purpose: Treatment Primary endpoint: Incidence of reaching the target serum trough concentration Secondary endpoint: Clinical efficiency, Antibiotic use, acute kidney injury.
Timeline
- Start
- 2019-10-01
- Primary completion
- 2022-05-31
- Completion
- 2022-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Vancomycin | Other / unclassified | — | — |